Social Groups for Autistic Young Adults (SDARIYA) (SDARIYA)

October 29, 2025 updated by: Matthew Lerner, Drexel University

Social Groups for Autistic Young Adults (SDARI)

This is a clinical trial that will test whether a group program called SDARI (Socio-dramatic Affective Relational Intervention) can help autistic young adults between the ages of 18 and 30 feel more connected to others and improve their social relationships.

The study will try to answer:

Can SDARI be used successfully with autistic adults? Does SDARI help people feel more connected, supported, and mentally well?

There are two groups in the study. One group will participate in the SDARI program, and the other group will do different structured activities that don't focus on social connection. Researchers will compare the two groups to see if SDARI leads to better outcomes.

Participants will:

Complete screening to confirm eligibility (including autism traits and IQ) Attend weekly in-person group sessions for 10 weeks Take part in games and activities designed to support connection and collaboration Complete surveys and interviews before, during, and after the program Have the option to choose someone close to them (like a friend or family member) to fill out surveys about their experiences

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The proposed study will evaluate the Socio-dramatic Affective Relational Intervention (SDARI) in autistic young adults aged 18-30 years. SDARI is a group-based, performance-oriented intervention designed to support interpersonal engagement through structured, drama-based activities. The intervention emphasizes experiential learning and minimizes didactic instruction, focusing instead on affectively motivating games, collaborative interactions, and age-appropriate recreational activities.

Participants will be recruited through community organizations, university outreach channels, and autism service agencies. Eligibility will be determined through a multi-step screening process, including the RAADS, ADOS-2 Module 4, and KBIT-2R assessments. Eligible participants will be randomized into either the SDARI intervention group or a time-matched attention control group. Each group will meet weekly for 90-minute sessions over a 10-week period at the AJ Drexel Autism Institute.

The SDARI curriculum integrates three core components:

Use of improvisational and drama-based games tailored to the developmental stage and interests of autistic young adults.

Facilitation of peer-to-peer and participant-staff relationships to foster positive reinforcement and group cohesion.

Incorporation of motivating activities such as noncompetitive physical games and shared-interest tasks to enhance engagement.

The attention control condition will follow the same schedule and structure but will involve recreational activities that do not explicitly promote interpersonal interaction.

Participants will complete assessments at three timepoints: baseline (pre-intervention), post-intervention, and three-month follow-up. Measures will include self-report and informant-report questionnaires assessing interpersonal experiences, social networks, group cohesion, and mental health. Social Network Analysis (SNA) will be used to evaluate changes in participants' social connections and network structures over time.

All sessions will be video-recorded for fidelity monitoring. Staff will receive condition-specific training and weekly supervision to ensure consistency and adherence to the intervention protocol.

The study aims to assess the feasibility, acceptability, and preliminary efficacy of SDARI in autistic adult populations. Outcomes will inform future adaptations and dissemination of SDARI for broader use in clinical and community settings.

Study Type

Interventional

Enrollment (Estimated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • Drexel University
        • Contact:
          • Matthew Lerner, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Have graduated from high school (or an equivalent program) and are between the ages of 18-30 years old
  • Demonstrate the ability to complete consent and all study measures and procedures in English
  • Score ≥ 65 on the RAADS
  • Score ≥ 70 on the KBIT-2R
  • Score ≥ 6 on the ADOS-2 Module 4
  • Are physically able to complete study activities (e.g., no significant physical impairment or mental condition restricting participation in study activities).
  • Are physically able to travel to the AJ Drexel Autism Institute at Drexel University in Philadelphia, PA to attend all weekly study sessions

Exclusion Criteria:

  • Are still enrolled in high school (or an equivalent program) or are not between the ages of 18-30 years old
  • Are unable to complete study measures and/or procedures in English
  • Are unable to complete consent procedures
  • Score ≤ 65 on the RAADS
  • Score ≤ 70 on the KBIT-2R
  • Score ≤ 6 on the ADOS-2
  • Cannot physically complete study activities
  • Cannot physically travel to the AJ Drexel Autism Institute at Drexel University in Philadelphia, PA to attend study sessions
  • Have a severe medical or psychiatric condition preventing them from safely completing study activities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SDARI-YA
follow SDARI Protocol

SDARI is a group-based, performance-based intervention designed to provide participants with opportunities to engage in and experience targeted interpersonal interactions, with minimal didactic instruction or instrumental reinforcement. The intervention consists of three core components:

SDARI utilizes affectively motivating acting games that are adapted for the developmental stage and characteristics of the target population.

Clinicians promote strong relationships among participants and between participants and clinicians by fostering a supportive and enjoyable environment, facilitating both structured and unstructured interactions, encouraging collaborative problem-solving, and reinforcing positive peer engagement.

SDARI incorporates motivating activities-such as noncompetitive physical games, shared interests, and goal-oriented tasks-to enhance interpersonal motivation and engagement.

Active Comparator: AYA
follow AYA Protocol

This group provides concrete presentation of thematic content and connects those themes to specific semi-structured, naturalistic games and activities. Themes are addressed and targeted according to the developmental needs of individual group members.

Core Program Principles include:

Use of recreational, motivational activities adapted for the target age range and population Positive reinforcement of interpersonal engagement through structured activities Integration of strong, age-appropriate motivators

The AYA program uniquely combines these elements to facilitate both development and enjoyment. Group members engage in increasingly complex interpersonal interactions within the group setting and gain motivation to generalize these experiences across other environments, including home and educational contexts.

Other Names:
  • Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Responsiveness
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
measured by the Social Responsiveness Scale-2 (min= 0 and max=195), higher score= worse outcomes
Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Friendship
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)

measured by the Quality of Socialization Questionnaire for Young Adults (QSQ-YA):

For the conflict subscale (min 0, max= 24), a higher score indicates worse outcomes.

For the frequency items (min 0, max n/a (i.e. questionnaire asks how many get togethers did you have in a week), a higher count of get-togethers or dates indicates better outcomes

Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Anxiety
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
measured by Anxiety Scale for Autism (Adults) (ASA-A) (min=0, max=60, a higher score=worse outcomes)
Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Depression
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
measured by The Patient Health Questionnaire (PHQ-9) (min=0, max=27, higher scores=worse outcomes)
Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Capacity for social and interpersonal pleasure
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
measured by the Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS) (min=17, max=102, higher scores indicate worse outcomes)
Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Cognitive flexibility
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
measured by the Cognitive Flexibility Inventory (CFI) (min=20, max= 140, higher scores indicate better outcomes)
Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Loneliness
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
measured by the UCLA Loneliness Scale - Revised (min=20, max=80, higher score indicates worse outcomes.
Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Social processes/dimensions
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)

Other informant report measured by the Stanford Social Dimensions Scale (SSDS) (Social Motivation (14 items): Scores range from 14 to 70.

Social Affiliation (8 items): Scores range from 8 to 40. Expressive Social Communication (7 items): Scores range from 7 to 35. Social Recognition (7 items): Scores range from 7 to 35. Unusual Approach (4 items): Scores range from 4 to 20; higher scores indicate better outcomes)

Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Empathy
Time Frame: Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
other informant report measured by the Toronto Empathy Questionnaire - Informant Version (TEQ-IV) (min=0, max=64, higher scores indicate better outcomes)
Day 1 (Baseline) Week 10 (Post-intervention) Week 22 (3-Month Follow-up)
Group cohesion
Time Frame: Week 1, Week 3, Week 5, Week 7, Week 8, Week 10
measured by the Group Cohesiveness Scale (GCS). (min=7 and max=35, higher scores indicate better outcomes)
Week 1, Week 3, Week 5, Week 7, Week 8, Week 10
Social networks
Time Frame: Day -14 to Day 0; Week 1 to Week 2; Week 11 to Week 12
as measured by Social Networks Survey (SNS) (min/max scores= N/A)
Day -14 to Day 0; Week 1 to Week 2; Week 11 to Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew Lerner, PhD, Drexel University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 15, 2026

Primary Completion (Estimated)

February 1, 2030

Study Completion (Estimated)

February 1, 2031

Study Registration Dates

First Submitted

October 1, 2025

First Submitted That Met QC Criteria

October 28, 2025

First Posted (Estimated)

October 30, 2025

Study Record Updates

Last Update Posted (Estimated)

October 31, 2025

Last Update Submitted That Met QC Criteria

October 29, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on SDARI-YA

Subscribe